Last update 09 May 2025

AR-100DP1

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AR 100DP1, AR100DP1
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Mild Atopic DermatitisModerate Atopic Dermatitis
Originator Organization
ARJIL Pharmaceuticals LLC
Active Organization-
Inactive Organization
ARJIL Pharmaceuticals LLC
License Organization-
Drug Highest PhaseDiscontinuedPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AR-100DP1
NCT04220411
/ TerminatedPhase 1/2
A Phase I/IIa Open-Label, Dose-Escalation Study to Determine the Safety, Tolerability, and Efficacy of AR100DP1 in Healthy Subjects, and Subjects With Mild to Moderate Atopic Dermatitis
100 Clinical Results associated with AR-100DP1
Login to view more data
100 Translational Medicine associated with AR-100DP1
Login to view more data
100 Patents (Medical) associated with AR-100DP1
Login to view more data
100 Deals associated with AR-100DP1
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mild Atopic DermatitisPhase 2
Taiwan Province
ARJIL Pharmaceuticals LLC
08 Dec 2020
Moderate Atopic DermatitisPhase 2
Taiwan Province
ARJIL Pharmaceuticals LLC
08 Dec 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free